Characterization of the Cuban biopharmaceutical industry from collaborative networks

Maria Victoria Guzmán-Sánchez (), Maybel Piñón-Lora (), Elio Atenógenes Villaseñor-García (), José Luis Jiménez-Andrade () and Humberto Carrillo-Calvet ()
Additional contact information
Maria Victoria Guzmán-Sánchez: Finlay Institute of Vaccines. BioCubaFarma
Maybel Piñón-Lora: Autonomous University of Mexico City (UACM)
Elio Atenógenes Villaseñor-García: Center of Research and Innovation in Information and Communication Technologies (INFOTEC)
José Luis Jiménez-Andrade: National Autonomous University of Mexico (UNAM)
Humberto Carrillo-Calvet: National Autonomous University of Mexico (UNAM)

Scientometrics, 2018, vol. 115, issue 3, No 25, 1533-1548

Abstract: Abstract Studies of scientific collaboration have introduced the concepts of collaborative networks. These networks may represent the social structure of a community of researchers or knowledge transmission in a specific country or economic sector. Cuban biopharmaceutical industry is an exceptional case study. This high-tech sector has achieved important development in the context of a “Third World” country, with a different political organization from the rest of the world. The main goal of this work is to characterize the Cuban biotechnology industry using collaborative networks. WoS database (1969–2016) was used and metric indicators of scientific collaboration obtained from the affiliation field. Netlike visualizations were produced with NodeXL software. BioCubaFarma meets about 50% of the total scientific production of all Cuban sectors. Since its foundation, the sector has maintained significant internal and external collaboration, with Europe, Latin America and the United States of America. The United States collaboration has been significant in the absence of diplomatic relations with that country. Collaboration is greater among centers of the old “scientific pole” than among old companies of the pharmaceutical sector. Moreover, there is a correlation between the magnitude of the scientific production and the collaboration levels. For the development of biomedicine in Cuba, collaboration has not been solely endogenous but has also represented a significant transfer of knowledge between Cuba and other countries.

Keywords: Collaborative networks; BioCubaFarma; Biopharmaceutical industry; Community of researchers; Scientific collaboration (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s11192-018-2719-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:scient:v:115:y:2018:i:3:d:10.1007_s11192-018-2719-5

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/11192

DOI: 10.1007/s11192-018-2719-5

Access Statistics for this article

Scientometrics is currently edited by Wolfgang Glänzel

More articles in Scientometrics from Springer, Akadémiai Kiadó
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().